Safety and Efficacy of Aliskiren on the Progression of Atherosclerosis in Coronary Artery Disease Patients
Status:
Completed
Trial end date:
2013-01-01
Target enrollment:
Participant gender:
Summary
The study will assess the change in coronary atherosclerotic disease as determined by
intravascular ultrasound (IVUS) for aliskiren compared to placebo when given in addition to
standard therapy in patients with coronary artery disease (CAD) and a blood pressure in the
pre-hypertensive range.